rxstat › Shortages › Ofatumumab

Ofatumumab shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ofatumumab products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 2
Reports on file
4

Reports by product

Discontinued
ARZERRA
100MG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02381559
Discontinued
ARZERRA
1000MG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02381567
Resolved
ARZERRA
100MG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02381559 · ended Sep 26, 2018 · Other (Please describe in comments)
Resolved
ARZERRA
1000MG · SOLUTION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02381567 · ended Sep 26, 2018 · Other (Please describe in comments)

What's happening

One or more Ofatumumab products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Ofatumumab is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XC).

Recent changes

Common questions

When will Ofatumumab be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ofatumumab in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other antineoplastic agents)

Widespread shortageCarboplatin2 of 3 reported products affectedPartial shortageAmsacrine1 of 1 reported products affectedPartial shortageArsenic Trioxide1 of 3 reported products affectedPartial shortageBortezomib3 of 7 reported products affected · est. return Aug 28, 2026Partial shortageEribulin1 of 1 reported products affected · est. return Dec 31, 2026Partial shortageErlotinib3 of 14 reported products affected · est. return Jun 30, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.